| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917980 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
MRI-guided single fraction radiotherapy with an integrated ablative boost to the GTV is dosimetrically feasible with both techniques. We perceive IMB less suitable for clinical implementation due to PTVCTV overdosage. Future studies have to confirm the clinical feasibility of the single fraction ablative approach.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ramona K. Charaghvandi, Mariska D. den Hartogh, Anne-Mar L.N. van Ommen, Wilfred J.H. de Vries, Vincent Scholten, Marinus A. Moerland, Mariëlle E.P. Philippens, Rogier I. Schokker, Marco van Vulpen, Bram van Asselen, Desirée H.J.G. van den Bongard,